Skip to main content
SpringerLink
Log in

Pertussis

  • Chapter
  • First Online:
Bacterial Infections of Humans

Bordetella pertussis produces a single disease syndrome in man known as pertussis or whooping cough. The disease characteristically displays a protracted course measured in weeks to months, with the development of vigorous paroxysmal coughing often associated with vomiting and whoop.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Holmes, W. H., Bacillary and Rickettsial Infections, Macmillan, New York (1940).

    Google Scholar 

  2. Lapin, J. H., Whooping Cough, Charles C. Thomas, Springfield, IL (1943).

    Google Scholar 

  3. Kloos, W. E., Mohapatra, N., Dobrogosz, W. J., et al., Deoxyribonucleotide sequence relationships among Bordetella species, Int. J. Syst. Bacteriol. 31:173–176 (1981).

    Google Scholar 

  4. Parkhill, J., Sebaihia, M., Preston, A., et al., Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica, Nat. Genet. 35:32–40 (2003).

    Google Scholar 

  5. Wardlaw, A. C., and Parton, R., The host–parasite relationship in pertussis, in: Pathogenesis and Immunity in Pertussis (A. C. Wardlaw and R. Parton, eds.), pp. 327–352, John Wiley, London (1988).

    Google Scholar 

  6. Bordet, J., and Gengou, O., Le microbe de la coqueluche, Ann. Inst. Pasteur 20:731–741 (1906).

    Google Scholar 

  7. Pittman, M., The concept of pertussis as a toxin-mediated disease, Pediatr. Infect. Dis. J. 3:467–486 (1984).

    CAS  Google Scholar 

  8. Dauer, C. C., Reported whooping cough morbidity and mortality in the United States, Public Health Rep. 58:661–676 (1943).

    Google Scholar 

  9. Mortimer, E. A., Jr., and Jones, P. K., An evaluation of pertussis vaccine, Rev. Infect. Dis. 1:927–932 (1979).

    PubMed  Google Scholar 

  10. Miller, D. L., Alderslade, R., and Ross, E. M., Whooping cough and whooping cough vaccine: the risks and benefits debate, Epidemiol. Rev. 4:1–24 (1982).

    PubMed  CAS  Google Scholar 

  11. Stewart, G. T., Pertussis vaccine: the United Kingdom’s experience, in: International Symposium on Pertussis (C. R. Manclark and J. C. Hill, eds.), pp. 262–278, Government Printing Office, Washington, DC (1979).

    Google Scholar 

  12. Onorato, I. M., and Wassilak, S. G. F., Laboratory diagnosis of pertussis: the state of the art, Pediatr. Infect. Dis. J. 6:145–151 (1987).

    PubMed  CAS  Google Scholar 

  13. Sutter, R. W., and Cochi, S. L., Pertussis hospitalizations and mortality, 1985–1988. Evaluation of the completeness of national reporting, J. Am. Med. Assoc. 267:386–391 (1992).

    CAS  Google Scholar 

  14. Shaikh, R., Guris, D., Strebel, P. M., and Wharton, M., Underreporting of pertussis deaths in the United States: need for improved surveillance, Pediatrics 101:323–324 (1998).

    PubMed  CAS  Google Scholar 

  15. Heininger, U., Stehr, K., Schmidt-Schlapfer, G., et al., Bordetella pertussis infections and sudden unexpected deaths in children, Eur. J. Pediatr. 155:551–533 (1996).

    PubMed  CAS  Google Scholar 

  16. Deeks, S., De Serres, G., Boulianne, N., et al., Failure of physicians to consider the diagnosis of pertussis in children, Clin. Infect. Dis. 28: 840–846 (1999).

    PubMed  CAS  Google Scholar 

  17. Olson, L. C., Pertussis, Medicine 54:427–469 (1975).

    PubMed  CAS  Google Scholar 

  18. Baraff, L. J., Wilkins, J., and Wehrle, P. F., The role of antibiotics, immunizations, and adenoviruses in pertussis, Pediatrics 61:224–230 (1978).

    PubMed  CAS  Google Scholar 

  19. Linneman, C. C., Host–parasite interactions in pertussis, in: International Symposium on Pertussis (C. R. Manclark and J. C. Hill, eds.), pp. 3–18, US Government Printing Office, Washington, DC, 1979.

    Google Scholar 

  20. Wirsing von König, C. W., Rott, H., Bogaerts, H., and Schmitt, H. J., A serologic study of organism possibly associated with pertussis like coughing, Pediatr. Infect. Dis. J. 17:645–649 (1998).

    Google Scholar 

  21. Hallander, H. O., Gnarpe, J., Gnarpe, H., and Olin, P. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae and persistant cough in children, Scand. J. Infect. Dis. 31:281–286 (1999).

    PubMed  CAS  Google Scholar 

  22. Gay, N. J., and Miller, E., Pertussis transmission in England and Wales, Lancet 355:1553–1554 (2000).

    PubMed  CAS  Google Scholar 

  23. Fine, P. E. M., and Clarkson, J. A., Distribution of immunity to pertussis in the population of England and Wales, J. Hyg. 92:21–26 (1984).

    CAS  Google Scholar 

  24. de Melker, H. E., Versteegh, F. G., Conyn-Van Spaendonck, M. A., et al., Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussi, J. Clin. Microbiol. 38(2):800–806 (2000).

    PubMed  Google Scholar 

  25. Baughman, A. L., Bisgard, K. M., Edwards, K. M., et al., Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States, Clin. Diagn. Lab. Immunol. 11(6):1045–1053 (2004).

    PubMed  CAS  Google Scholar 

  26. Mattoo, S., Cherry, J. D., Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella species, Clin. Microbiol. Rev. 18:326–382 (2005).

    PubMed  CAS  Google Scholar 

  27. Muller, F. M., Hoppe, J. E., Wirsing von Konig, C. H., Laboratory diagnosis of pertussis: state of the art in 1997, J. Clin. Microbiol. 35:2435–2443 (1997).

    PubMed  CAS  Google Scholar 

  28. Hallander, H. O., Reizenstein, E., Renemar, B., et al., Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis, J. Clin. Microbiol. 31:50–52 (1993).

    PubMed  CAS  Google Scholar 

  29. Strebel, P. M., Cochi, S. L., Farizo, K. M., et al., Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis, Clin. Infect. Dis. 16:276–285 (1993).

    PubMed  CAS  Google Scholar 

  30. Ewanowich, C. A., Chui, L. W., Paranchych, M. G., et al., Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology, J. Clin. Microbiol. 31: 1715–1725 (1993).

    PubMed  CAS  Google Scholar 

  31. He, Q., Mertsola, J., Soini, H., and Vijanen, M. K., Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens, J. Pediatr. 124:421–426 (1994).

    PubMed  CAS  Google Scholar 

  32. Schlapfer, G., Cherry, J. D., Heininger, V., et al., Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany, Pediatr. Infect. Dis. J. 14:209–214 (1995).

    PubMed  CAS  Google Scholar 

  33. Taranger, J., Trollfors, B., Lund, L., et al., Environmental contamination leading to false-positive polymerase chain reaction for pertussis, Pediatr. Infect. Dis. J. 13:936–937 (1994).

    PubMed  CAS  Google Scholar 

  34. Schmidt-Schlapfer, G., Liese, J. G., Stojanov, S., et al., Polymerase chain reaction (PCR) compared with conventional identification in culture for detection of Bordetella pertussis in 7153 children, Clin. Microbiol. Infect. 2:462–467 (1997).

    Google Scholar 

  35. Halperin, S. A., The control of pertussis—2007 and beyond [Invited Perspective article], N Engl J Med. 356:110–113 (2007).

    PubMed  CAS  Google Scholar 

  36. Muyldermans, G, Soetens, O., Antoine, M., et al., External quality assessment for molecular detection of Bordetella pertussis in European laboratories, J. Clin. Microbiol. 43:30–35 (2005).

    PubMed  CAS  Google Scholar 

  37. Marchant, C. D., Loughlin, A. M., Lett, S. M., et al., Pertussis in Massachusetts, 1981–1991: incidence, serological diagnosis, and vaccine effectiveness, J. Infect. Dis. 169:1297–1305 (1994).

    PubMed  CAS  Google Scholar 

  38. Weiss, A., Hewlett, E. L., Virulence factors of Bordetella pertussis, Annu. Rev. Microbiol. 40:661–686 (1986).

    PubMed  CAS  Google Scholar 

  39. Mortimer, E. A., Jr., Pertussis vaccine, in: Vaccines, 2nd ed. (S. A. Plotkin and E. A. Mortimer, Jr., eds.), pp. 91–135, W. B. Saunders, Philadelphia, 1994.

    Google Scholar 

  40. Steketee, R. W., Burstyn, D. G., Wassilak, S. G. F., et al., A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled, J. Infect. Dis. 157:441–449 (1988).

    PubMed  CAS  Google Scholar 

  41. Meade, B. D., Kind, P. D., and Manclark, C. R., Lymphocytosis promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation, Infect. Immun. 46:733–739 (1984).

    Google Scholar 

  42. Spangrude, G. J., Sacchi, F., Hill, H. R., et al., Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J. Immunol. 135:4135–4143 (1985).

    PubMed  CAS  Google Scholar 

  43. Arico, B., and Rappuoli, R., Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes, J. Bacteriol. 169:2847–2853 (1987).

    Google Scholar 

  44. Heininger, U., K. Stehr, S. Schmitt-Grohe, C. Lorenz, et al., Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis, Pediatr. Infect. Dis. J. 13:306–309 (1994).

    PubMed  CAS  Google Scholar 

  45. Thomas, M. G., Redhead, K., and Lambert, H. P., Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination, J. Infect. Dis. 159:211–218 (1989).

    PubMed  CAS  Google Scholar 

  46. Shahin, R. D., Brennan, M. J., Li, Z. M., et al., Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis, J. Exp. Med. 171:63–73 (1990).

    PubMed  CAS  Google Scholar 

  47. Emsley, P., McDermott, G., Charles, I. G., et al., Crystallographic characterization of pertactin, a membrane-associated protein from Bordetella pertussis, J. Mol. Biol. 235:772–773 (1996).

    Google Scholar 

  48. Cherry, J. D., Bornbein J., Heinninger, U., and Stehr, K., A search for serologic correlates of immunity to Bordetella pertussis cough illnesses, Vaccine 16:1901–1906 (1998).

    PubMed  CAS  Google Scholar 

  49. Storsaeter, J., Hallander, H. O., Gustafsson, L., and Olin, P., Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis, Vaccine 15:1907–1916 (1998).

    Google Scholar 

  50. Preston, N. W., Effectiveness of pertussis vaccines, Br. Med. J. 2: 11–13 (1965).

    Google Scholar 

  51. Centers for Disease Control and Prevention (CDC), Summary of notifiable diseases, United States 2004, Morb. Mortal. Wkly. Rep. 53:1–79 (2006).

    Google Scholar 

  52. Centers for Disease Control and Prevention (CDC), Summary of notifiable diseases, United States 2005, Morb. Mortal. Wkly. Rep. 54: 2–92 (2007).

    Google Scholar 

  53. Centers for Disease Control and Prevention (CDC), Pertussis—United States, 1997–2000, Morb. Mortal. Wkly. Rep. 51:73–76 (2002).

    Google Scholar 

  54. Centers for Disease Control and Prevention (CDC) National, State, and Urban Area Vaccination Coverage Among Children Aged 19–35 Months—United States, 2004 Morb. Mortal. Wkly. Rep. 54:717–721 (2005)

    Google Scholar 

  55. Tanaka, M., Vitek, C. R., Pascual, F. B., et al., Trends in pertussis among infants in the United States, 1980–1999, J. Am. Med. Assoc. 290:2968–2975 (2003).

    CAS  Google Scholar 

  56. Güris, D., Strebel, P. M., Bardenheier, B., et al., Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, Clin. Infect. Dis. 28:1230–1237 (1999).

    PubMed  Google Scholar 

  57. Yih, W. K., Lett, S. M., des Vignes, F. N., et al., The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998, J. Infect. Dis. 182:1409–1416 (2000).

    PubMed  CAS  Google Scholar 

  58. Robertson, P. W., Goldberg, H., Jarvie, B. H., et al., Bordetella pertussis infection: a cause of persistent cough in adults, Med. J. Australia 146:522–525 (1987).

    PubMed  CAS  Google Scholar 

  59. Mink, C. M., Sirota, N. M., Nugent, S., Outbreak of pertussis in a fully immunized adolescent an adult population, Arch. Pediatr. Adolesc. Med. 148: 153–157 (1994).

    PubMed  CAS  Google Scholar 

  60. Schmitt-Grohé, S., Cherry, J. D., Heininger, U., et al., Pertussis in German adults, Clin. Infect. Dis. 21:860–866 (1995).

    PubMed  Google Scholar 

  61. Postels-Multani, S., Schmitt, H. J., Wirsing von König, C. H., et al., Symptoms and complications of pertussis in adults, Infection, 23: 13–16 (1995).

    Google Scholar 

  62. Wright, S. W., Edwards, K. M., Decker, M. D., and Zeldin, M. H., Pertussis infection in adults with persistent cough, J. Am. Med. Assoc. 273:1044–1046 (1995).

    CAS  Google Scholar 

  63. Wirsing von König, C. H., Postels-Multani, S., Bock, H. L., and Schmitt, H. J., Pertussis in adults : frequency of transmission after household exposure, Lancet 346:1326–1329 (1995).

    Google Scholar 

  64. Nennig, M. E., Shinefield, H. R., Edwards, K. M., et al., Prevalence and incidence of adult pertussis in an urban population, J. Am. Med. Assoc. 275:1672–1674 (1996).

    CAS  Google Scholar 

  65. Lieberman, D., Shvartzman, P., Lieberman, D., et al., Etiology of respiratory tract infection in adults in a general practice setting, Eur. J. Clin. Microbiol. Infect. Dis. 17:685–689 (1998).

    PubMed  CAS  Google Scholar 

  66. Birkebaek, N. H., Kristiansen, M., Seefeldt, T., et al., Bordetella pertussis and chronic cough in adults, Clin. Infect. Dis. 29:1239–1242 (1999).

    PubMed  CAS  Google Scholar 

  67. Mertens, P. L., J. M., Stals, F. S., Schellekens, et al., An epidemic of pertussis among elderly people in a religious institution in The Netherlands, Eur. J. Clin. Microbiol. Infect. Dis. 18:242–247 (1999).

    PubMed  CAS  Google Scholar 

  68. Senzilet, L. D., Halperin, S. A., Spika, J. S., et al., Pertussis is a frequent cause of prolonged cough illness in adults and adolescents, Clin. Infect. Dis. 32:1691–1697 (2001).

    PubMed  CAS  Google Scholar 

  69. Beynon, K. A., Young, S. A., Laing, R. T., et al., Bordetella pertussis in adult pneumonia patients, Emerg. Infect. Dis. 11:639–641 (2005).

    PubMed  Google Scholar 

  70. Strebel, P., Nordin, J., Edwards, K., et al., Population based incidence of pertussis among adolescents and adults, Minnesota 1995–1996, J. Infect. Dis. 183:1353–1359 (2001).

    PubMed  CAS  Google Scholar 

  71. Ward, J. I., Cherry, J. D., Chang, S. J., et al., Immunization of adolescents and adults with an acellular pertussis vaccine: results of a national randomized protective efficacy trial, N. Engl. J. Med. 353:1555–1563 (2005).

    PubMed  CAS  Google Scholar 

  72. Nardone, A., Pebody, R. G., Maple, P. A., et al., Sero-epidemiology of Bordetella pertussis in England and Wales, Vaccine 12:22:1314–1319 (2004).

    Google Scholar 

  73. Pebody, R. G., Gay, N. J., Giammanco, A., et al., The seroepidemiology of Bordetella pertussis infection in Western Europe, Epidemiol. Infect. 133:159–171 (2005).

    PubMed  CAS  Google Scholar 

  74. Vitek, C. R., Pascual, F. B., Baughman, A. L., and Murphy, T. V., Increase in deaths from pertussis among young infants in the United States in the 1900s, Ped. Infect. Dis. 22:628–634 (2003).

    Google Scholar 

  75. Srivasta, P., Unpublished data from the Centers for Disease Control and Prevention, personal communication (2007).

    Google Scholar 

  76. Bassili, W. R., and Stewart, G. T., Epidemiological evaluation of immunization and other factors in the control of whooping cough, Lancet 1:471–474 (1976).

    PubMed  CAS  Google Scholar 

  77. Ehrengut, W., Whooping cough vaccination: comment on report from the Joint Committee on Vaccination and Immunisation, Lancet 1:370–371 (1978).

    PubMed  CAS  Google Scholar 

  78. Gordon, J. E., and Hood, R. I., Whooping cough and its epidemiological anomalies, Am. J. Med. Sci. 222:333–361 (1951).

    PubMed  CAS  Google Scholar 

  79. Stewart, G. T., Whooping cough and pertussis vaccine : a comparison of risks and benefits in Britain during the period 1968–1983, Dev. Biol. Stand. 61:395–405 (1984).

    Google Scholar 

  80. Miller, E., Vurdien , J. E., White, J. M., The epidemiology of pertussis in England and Wales, Commun. Dis. Rep. 2:R152–154 (1992).

    CAS  Google Scholar 

  81. World Health Organization. Statistics on pertussis. http://www.who.int/immunization_monitoring/diseases/pertussis/en/index.html accessed October 17 (2005).

  82. Mikelova, L. K., Halperin, S. A., Scheifele, D., et al., Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada, J. Pediatr. 143:576–581(2003).

    PubMed  Google Scholar 

  83. Sako, W., Studies on pertussis immunization, J. Pediatr. 30:29–40 (1947).

    PubMed  CAS  Google Scholar 

  84. Gustafsson, L., Hallander, H. O., Olin, P., et al., A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine, N. Engl. J. Med. 334:349–355 (1996).

    PubMed  CAS  Google Scholar 

  85. Greco, D., Salmaso, S., Mastrantonio, P., et al., A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N. Engl. J. Med. 334:341–348 (1996).

    PubMed  CAS  Google Scholar 

  86. Clark, A. C., Bradford, W. L., and Berry, G. P., An epidemiological study of an outbreak of pertussis in a public school, Am. J. Public Health 36:1156–1162 (1946).

    Google Scholar 

  87. Centers for Disease Control and Prevention (CDC), Pertussis outbreak among adults at an oil refinery—Illinois, August–October 2002, Morb. Mortal. Wkly. Rep. 52:1–4 (2003).

    Google Scholar 

  88. Centers for Disease Control and Prevention (CDC), School-associated pertussis outbreak—Yavapai County, Arizona, September 2002–February 2003, Morb. Mortal. Wkly. Rep. 53:216–219 (2004).

    Google Scholar 

  89. Wheeler, J. G., Tran, T. C., North, P., et al., Barriers to public health management of a pertussis outbreak in Arkansas, Arch. Pediatr. Adolesc. Med. Feb 158(2):146–152 (2004).

    Google Scholar 

  90. Christie, C. D. C., Marx, M. L., Marchant, C. D., and Reising, S. F., The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children, N. Engl. J. Med. 331:16–21 (1994).

    PubMed  CAS  Google Scholar 

  91. Centers for Disease Control and Prevention, Resurgence of pertussis—United States, 1993, Morb. Mortal. Wkly. Rep. 42:952–953, 959–960 (1993).

    Google Scholar 

  92. Centers for Disease Control and Prevention, Pertussis outbreaks—Massachusetts and Maryland, 1992, Morb. Mortal. Wkly. Rep. 42:197–200 (1993).

    Google Scholar 

  93. Centers for Disease Control and Prevention (CDC), Pertussis outbreak—Vermont 1996, Morb. Mortal. Wkly. Rep. 46:822–826 (1997).

    Google Scholar 

  94. Skowronski, D. M., De Serres, G., MacDonald, et al., The changing age and seasonal profile of pertussis in Canada, J. Infect. Dis. 185(10):1448–1453 (2002).

    Google Scholar 

  95. Ntezayabo, B., De Serres, G., Duval, B., Pertussis resurgence in Canada largely caused by a cohort effect, Pediatr. Infect. Dis. J. 22:22–27 (2003).

    PubMed  Google Scholar 

  96. Farizo, K. M., Cochi, S. L., Zell, E. R., et al., Epidemiological features of pertussis in the United States, 1980–1989, Clin. Infect. Dis. 14:708–719 (1992).

    PubMed  CAS  Google Scholar 

  97. Kendrick P, Elderling G., Significance of bacteriological methods in the diagnosis and control of whooping cough. Am. J. Public Health 25:147–155 (1935)

    CAS  Google Scholar 

  98. Kendrick P, Eldering G. A study in active immunization against pertussis, Am. J. Hyg. B., 29:133–159 (1939).

    Google Scholar 

  99. Huovila, R., The effect of early erythromycin treatment on the infectiousness of whooping cough patients, Acta Paediatr. Scand. Suppl. 298:10–12 (1982).

    Google Scholar 

  100. Kwantes, W., Joynson, D. H. M., and Williams, W. O., Bordetella pertussis isolation in general practice: 1997–79 whooping cough epidemic in West Glamoran, J. Hyg. Camb. 90:149–158 (1983).

    PubMed  CAS  Google Scholar 

  101. Preziosi, M. P., and Halloran, M. E., Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness, Vaccine 21:1853–1861 (2003).

    PubMed  Google Scholar 

  102. He, Q., Arvilommi, H., Viljanen, M. K., and Mertsola, J., Outcome of Bordetella infections in vaccinated children: effects of bacterial number in the nasopharynx and patient age, Clin. Diagnost. Lab. Immunol. 6:534–536 (1999).

    CAS  Google Scholar 

  103. Expanded Programme on Immunization, EPI for the 1990s, World Health Organization, Geneva (1992).

    Google Scholar 

  104. Fine, P. E. M., and Clarkson, J. A., Seasonal influences on pertussis, Int. J. Epidemiol. 15:237–247 (1986).

    PubMed  CAS  Google Scholar 

  105. Clegg, E. J., Infectious disease mortality in two Outer Hebridean islands: 1. measles, pertussis and influenza, Ann. Hum. Biol. 30:455–471 (2003).

    PubMed  CAS  Google Scholar 

  106. Bradford, W. L., Use of convalescent blood in whooping cough, Am. J. Dis. Child. 50:918–928 (1935).

    Google Scholar 

  107. Kendrick, P. L., Secondary attack rates from pertussis in vaccinated and unvaccinated children, Am. J. Hyg. 32:89–91 (1940).

    Google Scholar 

  108. Church, M. A., Evidence of whooping-cough-vaccine efficacy from the 1978 whooping-cough epidemic in Hertfordshire, Lancet 2:188–190 (1979).

    PubMed  CAS  Google Scholar 

  109. Noble, G. R., Bernier, R. H., Esber, E. C., et al., Acellular and whole-cell pertussis vaccines in Japan: report of a visit by US scientists, J. Am. Med. Assoc. 257:1351–1356 (1987).

    CAS  Google Scholar 

  110. Wortis, N., Strebel, P. M., Wharton, M., et al., Pertussis deaths: report of 23 cases in the United States, 1992 and 1993, Pediatrics 97:607–612 (1996).

    PubMed  CAS  Google Scholar 

  111. Halperin, S. A., Wang, E. E. L., Law, B., et al., Epidemiological features of pertussis in hospitalized patients in Canada, 1991–1997: report of the Immunization Monitoring Program–Active (IMPACT), Clin. Infect. Dis. 28:1238–1243 (1999).

    PubMed  CAS  Google Scholar 

  112. De Serres, G., Shadmani, R., Duval, B., et al., Morbidity of pertussis in adolescents and adults, J. Infect Dis. 182:174–179 (2000).

    PubMed  Google Scholar 

  113. Rosenfeld, G. B., and Bradley, C., Childhood behavior sequelae of asphyxia in infancy with special reference to pertussis and asphyxia neonatorum, Pediatrics 2:74–83 (1948).

    PubMed  CAS  Google Scholar 

  114. Byers, R. K., and Rizzo, N. D., A follow-up study of pertussis in infancy, N. Engl. J. Med. 242:887–891 (1950).

    PubMed  CAS  Google Scholar 

  115. Litvak, A. M., Gibel, H., Rosenthal, S. E., and Rosenblatt, P., Cerebral complications in pertussis, J. Pediatr. 32:357–379 (1948).

    PubMed  CAS  Google Scholar 

  116. Miller, D., Wadsworth, J., Diamond, J., and Ross, E., Pertussis vaccine and whooping cough as risk factors for acute neurological illness and death in young children, Dev. Biol. Stand. 61:385–394 (1985).

    Google Scholar 

  117. Nelson, J. D., The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection, Am. J. Dis. Child. 132:371–373 (1978).

    PubMed  CAS  Google Scholar 

  118. Trollfors, B., and Rabo, E., Whooping cough in adults, Br. Med. J. 283:696–697 (1981).

    CAS  Google Scholar 

  119. Mortimer, E. A., Jr., Perspectives. Pertussis and its prevention: a family affair, J. Infect. Dis. 161:473–479 (1990).

    PubMed  Google Scholar 

  120. Long, S. S., Welkon, C., and Clark, J. L., Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology, J. Infect. Dis. 161:480– 486 (1990).

    PubMed  CAS  Google Scholar 

  121. Mink, C. A. M., Cherry, J. D., Christenson, P., et al., A search for Bordetella pertussis infection in university students, Clin. Infect. Dis. 14:464–471 (1992).

    PubMed  CAS  Google Scholar 

  122. Aoyama, T., Takeuchi, Y., Goto, A., et al., Pertussis in adults, Am. J. Dis. Child. 146:163–166 (1992).

    PubMed  CAS  Google Scholar 

  123. Cromer, B. A., Goydos, J., Hackell, J., et al., Unrecognized pertussis infection in adolescents, Am. J. Dis. Child. 147:575–577 (1993).

    PubMed  CAS  Google Scholar 

  124. Halperin, S. A., and Marrie, T. J., Pertussis encephalopathy in an adult: case report and review, Rev. Inf. Dis. 13:1043–1047 (1991).

    CAS  Google Scholar 

  125. Skowronski, D. M., Buxton, J. A., Hestrin, M., et al., Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review, Clin. Infect. Dis. 36:e1–e4 (2003). Available from: URL: http://www.journals.uchicago.edu/CID/journal/issues/v36n1/020600/020600.hmtl.

  126. Olin, P., Rasmussen, F., Gustafsson, L., et al., Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines, Lancet 350: 1569–1577 (1997).

    PubMed  CAS  Google Scholar 

  127. Knowles, K., Lorange, M., Matthews, R. C., and Preston, N. W., Characterization of outbreak and vaccine strains of Bordetella pertussis—Quebec, Can. Comm. Dis. Rep. 91–21:182–187 (1993).

    Google Scholar 

  128. Winsnes, R., Serological responses to pertussis, in: Pathogenesis and Immunity in Pertussis (A. C. Wardlaw and R. Parton, eds.), pp. 283–307, John Wiley, New York (1988).

    Google Scholar 

  129. Mills, K H. G., Barnard, A. L., Watkins, J., and Redhead, K., Cell mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model, Infect. Immun. 61:399 (1993).

    PubMed  CAS  Google Scholar 

  130. Redhead, K., Barnard, A., Watkins, J., and Miles, K. H. G., Effective immunization against Bordetella pertussis is dependent on induction of cell-mediated immunity, Infect. Immun. 61:3190 (1993).

    PubMed  CAS  Google Scholar 

  131. Mills, K. H. G., and Redhead, K., Cellular immunity in pertussis, J. Med. Microbiol. 39:163–164 (1993).

    PubMed  CAS  Google Scholar 

  132. Butler, N. R., Haslum, M., Golding, J., and Stewart-Brown, S., Recent findings from the 1970 child health and education study: preliminary communication, J. Roy. Soc. Med. 75:781–784 (1982).

    PubMed  CAS  Google Scholar 

  133. Britten, N., and Wadsworth, J., Long-term respiratory sequelae of whooping cough in a nationally representative sample, Br. Med. J. 292:441–444 (1986).

    CAS  Google Scholar 

  134. Johnston, I. D. A., Bland, J. M., and Ingram, D., Effect of whooping cough in infancy on subsequent lung function and bronchial reactivity, Am. Rev. Respir. Dis. 134:270–275 (1986).

    PubMed  CAS  Google Scholar 

  135. Granstrom, G., and Granstrom, M., Effect of erythromycin treatment on antibody responses in pertussis, J. Infect. Dis. 26:453–457 (1994).

    Google Scholar 

  136. World Health Organization. 1991. WHO meeting on case definition of pertussis: Geneva, 10–11 January 1991. Issue no. MIN/EP1/ PERT/91.1. WHO Geneva, Switzerland.

    Google Scholar 

  137. Centers for Disease Control and Prevention (CDC), Guidelines for the Control of Pertussis Outbreaks, Centers for Disease Control and Prevention, Atlanta, GA, 2000 (amendments made in 2005 and 2006), www.cdc.gov/nip/publications/pertussis/guide.htm.

  138. Halperin, S. A, Bortolussi, R., Langley, J., et al., Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections, Pediatrics 100:65–71 (1997).

    PubMed  CAS  Google Scholar 

  139. Langley, J. M., Halperin, S. A., Boucher, F. D., and Smith, B., Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC), Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis, Pediatrics 114:e96–101 (2004). Available from: URL: http://www.pediatrics.org/cgi/content/ full/114/1/e96.

  140. Halperin, S. A., Bortolussi, R., Langley, J. M., et al., randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection, Pediatrics 104(4):e42. (1999). Available from: URL: http://www.pediatrics.org/cgi/content/full/104/4/e42.

  141. Lebel, M. H., and Mehra, S., Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial, Pediatr. Infect. Dis. J. 20:1149–1154 (2001).

    PubMed  CAS  Google Scholar 

  142. Dodhia, H., Miller, E. Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. Epidemiol Infect 120:143–149 (1998).

    PubMed  CAS  Google Scholar 

  143. Steketee, R. W., Wassilak, S. Adkins, W. N., et al., Evidence for high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled, J. Infect. Dis. 157:434–440 (1988).

    Google Scholar 

  144. Sprauer, M. A., Cochi, S. L., Zell, E. R. et al., Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am. J. Dis. Child. 146:177–181 (1992).

    PubMed  CAS  Google Scholar 

  145. De Serres, G., Boulianne, N., Duval, B. Field effectiveness of erythromycin prophylaxis to prevent pertussis within families. Pediatr. Infect. Dis. J. 14:969–75 (1995).

    PubMed  Google Scholar 

  146. Morris, D., and McDonald, J. C., Failure of hyperimmune gamma globulin to prevent whooping cough, Arch. Dis. Child. 32:236–239 (1957).

    Google Scholar 

  147. Granstrom, M., Olinder-Nielsen, A. M., Holmblad, P., et al., Specific immunoglobulin for treatment of whooping cough, Lancet 338:1230–1233 (1992).

    Google Scholar 

  148. Ichimaru, T., Ohara, Y., Hojo, M., et al., Case report. Treatment of severe pertussis by administration of specific gamma globulin with high titer anti-toxin antibody, Acta Paediatr. 82:1076–1078 (1993).

    Google Scholar 

  149. Bruss J., Malley R., Halperin, S., et al., Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin, Pediatr. Infect. Dis. J. 18:505–511 (1999).

    PubMed  CAS  Google Scholar 

  150. Halperin, S. A., Vaudry, W., Boucher, F. C., et al., Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yet, Pediatr. Infect. Dis. J. 26:79–81 (2007).

    PubMed  Google Scholar 

  151. Onorato, I. M., Wassilak, S. G., and Meade, B., Efficacy of whole cell pertussis vaccine in preschool children in the United States, J. Am. Med. Assoc. 267:2745–2749 (1992).

    Google Scholar 

  152. Cherry, J. D., The epidemiology of pertussis and pertussis vaccine in the United Kingdom and the United States: a comparative study, Current Problems in Pediatrics 14:1–78 (1984).

    PubMed  CAS  Google Scholar 

  153. Hirtz, D. G., Nelson, K. B., and Ellenberg, J. H., Seizures following childhood immunizations, J. Pediatr. 102:14–18 (1983).

    PubMed  CAS  Google Scholar 

  154. Cody, C. L., Baraff, L. J., Cherry, J. D., et al., Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children, Pediatrics 68:650–660 (1981).

    PubMed  CAS  Google Scholar 

  155. Department of Health and Social Security, Committee on Safety of Medicines and Joint Committee on Vaccination and Immunization, Whooping Cough, Her Majesty’s Stationery Office, London (1981).

    Google Scholar 

  156. Miller, D., Madge, N., Diamond, J., et al., Pertussis immunization and serious acute neurological illness in children, Br. Med. J. 307:1171–1176 (1993).

    CAS  Google Scholar 

  157. Howson, C. P., and Fineberg, H. V., Adverse events following pertussis and rubella vaccines: summary of a report of the Institute of Medicine, J. Am. Med. Assoc., 267:392–396 (1992).

    CAS  Google Scholar 

  158. Halsey, N. A., Chesney, P. J., Gerber, M. A., et al., The relationship between pertussis vaccine and central nervous system sequelae: continuing assessment. Committee on Infectious Diseases, American Academy of Pediatrics, Pediatrics 97:279–281 (1996).

    Google Scholar 

  159. Kanai, K., Japan’s experience in pertussis epidemiology and vaccination in the past thirty years, Jpn. J. Sci. Biol. 33:107–143 (1980).

    CAS  Google Scholar 

  160. Romanus, V., Jonsell, R., and Bergquist, S. E., Pertussis in Sweden after the cessation of general immunization in 1979, Pediatr. Infect. Dis. J. 6:364–371 (1987).

    PubMed  CAS  Google Scholar 

  161. Edwards, K. M., Meade, B. D., Decker, M. D., et al., Comparison of 13 acellular pertussis vaccines: overview and serologic response, Pediatrics 96(Suppl.):548–557 (1995).

    PubMed  CAS  Google Scholar 

  162. Decker, M. D., Edwards, K. M., Steinhoff, M. C., et al., Comparison of thirteen acellular pertussis vaccines: adverse reactions, Pediatrics 96(Suppl.):557–566 (1995).

    PubMed  CAS  Google Scholar 

  163. Cherry, J. D., Comparative efficacy of acellular pertussis vaccines: a analysis of recent trials, Pediatr. Infect. Dis. J. 16:S90–96 (1997).

    PubMed  CAS  Google Scholar 

  164. Trollfors, B., Taranger, J., Lagergard, T., et al., A placebo-controlled trial of a pertussis-toxoid vaccine, N. Engl. J. Med. 333:1045–1050 (1995).

    PubMed  CAS  Google Scholar 

  165. Simondon, F., Preziosi, M. P., Yam, A., et al., A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal,Vaccine 15:1606–1612 (1997).

    PubMed  CAS  Google Scholar 

  166. Liese, J. G., Meschievitz, C. K., Harzer, E., et al., Efficacy of a two-component acellular pertussis vaccine in infants, Pediatr. Infect. Dis. J. 16:1038–1044 (1997).

    PubMed  CAS  Google Scholar 

  167. Stehr, K., Cherry, J. D., Heininger, U., et al., Comparative efficacy trial in Germany in infants who received either the Lederle/ Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine, Pediatrics 101:1–11 (1998).

    PubMed  CAS  Google Scholar 

  168. Salmaso, S., Mastrantonio, P., Tozzi, A. E., et al., Stage III Working Group. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience, Pediatrics 108:e81 (2001).

    PubMed  CAS  Google Scholar 

  169. Le Saux, N., Barrowman, N. J., Moore, D. L., et al., Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 112:e348–353 (2003). Available from: URL: http://www.pediatrics.org/cgi/ content/full/112/5/e348.

  170. Moore, D. L., Le Saux, N., Scheifele, D., et al., Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993–2002, Pediatr. Infect. Dis. J. 23:568–571 (2004).

    PubMed  Google Scholar 

  171. Halperin, S. A., Scheifele, D., Barreto, L., et al., Comparison of a fifth dose of a five-component acellular or a whole-cell pertussis vaccine in children four to six years of age, Pediatr. Inf. Dis. J. 18:772–779 (1999).

    CAS  Google Scholar 

  172. Scheifele, D. W., Halperin, S. A., and Ferguson, A. C., Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens, Vaccine 19:4720–4726 (2001).

    PubMed  CAS  Google Scholar 

  173. Halperin, S. A., Scheifele, D., Mills, E., et al., Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine, Vaccine 21:2298–2306 (2003).

    PubMed  CAS  Google Scholar 

  174. Skowronski, D. M., Remple, V. P., Macnabb, J., et al., Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact, Pediatrics 112:e453–e459 (2003) Available from: URL: http://www.pediatrics.org/cgi/content/ full/112/6/e453.

  175. National Advisory Committee on Immunization (NACI), Prevention of pertussis in adolescents and adults, Can. Commun. Dis. Rep. 29(ACS 5,6):1–9 (2003).

    Google Scholar 

  176. Centers for Disease Control and Prevention, Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm. Rep. 55(RR-3):1–44 (2006).

    Google Scholar 

  177. Centers for Disease Control and Prevention, Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel, MMWR Recomm. Rep. 55(RR-17):1–37 (2006).

    Google Scholar 

Suggested Reading

  • Institute of Medicine. (Howson, C. P., Howe, C. J., and Fineberg, H. V., editors). Adverse Effects of Pertussis and Rubella Vaccine, National Academy Press, Washington, DC. (1991).

    Google Scholar 

  • Mortimer, E. A., Jr., Pertussis vaccine, in: Vaccines, 2nd ed. (S. A. Plotkin and E. A. Mortimer, editors) pp. 91–135, W. B. Saunders, Philadelphia (1994).

    Google Scholar 

  • Wardlaw, A. C., and Parton, R., editors. Pathogenesis and Immunity in Pertussis, John Wiley, London (1988).

    Google Scholar 

Download references

Acknowledgment

We gratefully acknowledge the contribution of the late Dr. Edward A. Mortimer, Jr. who was the former author of this chapter that formed the foundation for the current version. Ted’s contribution to pertussis epidemiology can be updated but never replaced.

Author information

Authors and Affiliations

  1. Clinical Trials Research Center, Dalhousie University, IWK Health Centre, 5850/5980, University Avenue, Halifax, NS B3K 6R8, Canada

    Scott A. Halperin

Authors
  1. Scott A. Halperin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gaston De Serres
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Rollins School of Public Health, Emory University, Clifton Road NE., 1518, Atlanta, 30322, U.S.A.

    Philip S. Brachman

  2. College of Medicine, Office of Faculty Affairs, Drexel University, Race Street 1505, Philadelphia, 19102, U.S.A.

    Elias Abrutyn

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Halperin, S.A., De Serres, G. (2009). Pertussis. In: Brachman, P., Abrutyn, E. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09843-2_27

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-09843-2_27

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-09842-5

  • Online ISBN: 978-0-387-09843-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation